USPTO serial 99687130
SEEK LABS
Reviewed by CopyMark Law Group
Status 641Office Action
- Filing date
- Status date
- Registration date
- —
- Examiner
- DIEFENBACH, LINDSEY OLSON
- Law office
- TMO LAW OFFICE 136
What this means
The USPTO has issued an Office Action on this application. A response is typically required before the deadline, or the application can be abandoned.
Need help with SEEK LABS?
If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.
Current trademark owner
Get help with this Office Action, set up monitoring, or talk with CopyMark.
Not the owner?
File a new U.S. trademark application, or speak with our attorneys.
Owner
Salt Lake City, UT, US
Attorney of record
The USPTO lists this attorney as the applicant's representative for correspondence on this application.
Aaron D. Hendelman
Aaron D. Hendelman WILSON SONSINI GOODRICH & ROSATI650 Page Mill RoadPalo Alto, CA 94304United StatesGoods and services
| Class | Description | Status | First use |
|---|---|---|---|
| 042 | Providing medical and scientific research information in the fields of pharmaceuticals, therapeutics, diagnostics, biotechnology, healthcare, medicines, vaccines, in the fields of infectious diseases, oncology, rare diseases and treatment options; pharmaceutical research and development; pharmaceutical products development; research and development in the field of therapeutics, biotechnology, diagnostics, vaccines, infectious diseases, oncology, and rare diseases; technical scientific consultation and product development for others in the field of infectious diseases; scientific and technological services, namely, research and design in the field of machine learning and artificial intelligence for use in science, chemistry, biology, biochemistry, biotechnology, medicine and healthcare, and design and optimization of drugs; platform as a service (PAAS) featuring computer software platforms for use in optimizing drugs, therapeutics, and pharmaceuticals; research and development of pharmaceutical drugs to treat diseases utilizing a proprietary drug discovery platform; drug discovery services; design and development of computer software; medical and scientific research in the field of machine learning and artificial intelligence models | ACTIVE | Oct 31, 2025 |
| 044 | Providing information in the fields of pharmaceuticals, therapeutics, diagnostics, biotechnology, healthcare, medicines, vaccines, health conditions, health awareness and treatment options; medical information services, namely, providing information related to healthcare, diseases, disorders, and treatment options; online information services, namely, providing a website related to healthcare, health awareness, medicines, vaccines, diseases, disorders, and treatment options | ACTIVE | Jun 23, 2025 |
Related trademarks
CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.
Prosecution history
| Date | Code | Event | What it means |
|---|---|---|---|
| Sep 17, 2026 | XELG | APPLICATION EXTENSION GRANTED/RECEIPT PROVIDED | — |
| Sep 17, 2026 | XELR | APPLICATION EXTENSION TO RESPONSE PERIOD - RECEIVED | — |
| Jun 29, 2026 | GNRN | NOTIFICATION OF NON-FINAL ACTION E-MAILED | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| Jun 29, 2026 | GNRT | NON-FINAL ACTION E-MAILED | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| Jun 29, 2026 | CNRT | NON-FINAL ACTION WRITTEN | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| Jun 17, 2026 | DOCK | ASSIGNED TO EXAMINER | — |
| Mar 6, 2026 | MAFR | APPLICATION FILING RECEIPT MAILED | — |
| Mar 6, 2026 | NWOS | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED | — |
| Mar 6, 2026 | NWAP | NEW APPLICATION ENTERED | — |